Lymphoproliferative Disorders
Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil
... CD30+ lymphoproliferative disorders (pc-CD30-LPD) include the closely related T lympho- proliferative disorders primary cutaneous anaplastic large cell lymphoma (pcALCL), lymphomatoid papulosis (LyP) ...
8
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders
... a lymphoproliferative disease (61%) and in 7 of them by a solid tumor ...with lymphoproliferative diseases observed for a period of 9 years (2005–2014), indolent lymphoproliferative disorders ...
7
Immune signatures in human PBMCs of idiotypic vaccine for HCV related lymphoproliferative disorders
... the lymphoproliferative disorder may be sustained by mono-, oligo- or polyclonal B ...these lymphoproliferative disorders with the recognition of a limited number of HCV antigens ...
11
Original Article Clinicopathological characteristics of four cases of EBV positive T-cell lymphoproliferative disorders of childhood in China
... It has been proven that the Epstein-Barr virus (EBV) can infect B cells, T cells and natural kil- ler (NK) cells, and can result in various types of lymphoproliferative disorders containing B-cell, T-cell, ...
9
The MYC /miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential
... in lymphoproliferative disorders, including diagnostic/prognostic implications, and on the potential applications of anti-miRNAs based therapies targeting miRNAs belonging to the ...
12
Role of Hepatitis C Virus Infection on Lymphoproliferative Disorders after Non-liver Transplantation
... of lymphoproliferative disorders occurring in non liver organ transplant patients with regard to their HCV test ...“lymphoproliferative disorders + renal/Bonemarrow/heart/lung/ transplantation ...
9
Clinico-pathological analysis of lymphoproliferative disorders: a 3 year study
... Lymphoproliferative disorders are a heterogenous group of neoplasms of lymphoid cells, including B, T or NK cells. The incidence of these neoplasms has shown a rising trend in many countries. Lymphomas ...
5
Rituximab Is Indispensable for Pediatric Heart Transplant Recipients Developing Post transplant Lymphoproliferative Disorders
... in lymphoproliferative disorders occurring in heart transplant ...“lymphoproliferative disorders + transplantation + heart + survival” “lymphoproliferative disorders + ...
10
Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders
... Post-transplant lymphoproliferative disorders of T- or NK-cell origin (T/NK-PTLD) are rare entities and their genetic basis is unclear. We performed targeted sequencing of 465 cancer-related genes and ...
13
Orbital Lymphoproliferative Disorders (OLPDs): Value of MR Imaging for Differentiating Orbital Lymphoma from Benign OPLDs
... orbital lymphoproliferative disorders (29 orbital lymphomas and 18 benign orbital lymphoproliferative disorders) were ...orbital lymphoproliferative disorders were determined ...
7
Prevalence of Hepatitis C Virus in Lymphoproliferative Disorders
... Results: There was no significant difference for risk factors for hepatitis C virus infection in both the groups except for the increase in number of surgical procedures being carried out in the control group. There was ...
5
Incidental Malignant Lymphoma and Lymphoproliferative Disorders in Lymph Node Dissection Specimens during Tumor Removal in Various Organs
... There were 5 cases found of incidental lymphoma and lymphoproliferative disorders in lymph node dissection specimens during tumor removal. The results are presented in Table 2. There was 1 case of ...
6
Epstein Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice
... development (within 19-33 d) of aggressive, fatal, lymphoproliferative disorders of human B cell origin. Autopsies revealed solid tumors in the abdomen, and occasionally in the liver, thymus, or spleen. ...
6
Normalized Quantification by Real Time PCR of Epstein Barr Virus Load in Patients at Risk for Posttransplant Lymphoproliferative Disorders
... The load of Epstein-Barr virus (EBV) in peripheral blood mononuclear cells of transplant recipients represents a predictive parameter for posttransplant lymphoproliferative disorders (PTLD). The aim of our ...
6
Occult Hepatitis C Virus Infection in Spanish Patients with Lymphoproliferative Disorders
... Early after its discovery, it was shown that HCV is also a lymphotropic virus [2] being able to infect and replicate in established B cell lines and primary B lymphocytes [3], as well as in T cell lines and primary naïve ...
5
Post transplant lymphoproliferative disorders and Epstein Barr virus DNAemia in a cohort of lung transplant recipients
... In patient #5 a routine CT scan analysis performed four months after transplantation showed a non-infiltra- tive nodular lesion lacking contrast enhancement in the left lower lobe. Positron emission tomography (PET) ...
5
Increased Protection from Vaccinia Virus Infection in Mice Genetically Prone to Lymphoproliferative Disorders
... Mutations in the genes that encode Fas or Fas ligand (FasL) can result in poor restraints on lymphocyte activation and in in- creased susceptibility to autoimmune disorders. Because these mutations portend a ...
13
Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders
... Results To demonstrate the utility of determining the structure of the Ig and TcR genes in classifying lymphomas and to determine the clonal nature of other proliferative diseases of the[r] ...
7
Hepatic methotrexate associated lymphoproliferative disorders identified by multiple liver tumors: a case report and review of the literature
... Physicians should discontinue methotrexate in patients with rheumatoid arthritis treated with methotrexate when elevated soluble interleukin-2 receptor and hypovascular lesions in contra[r] ...
7
High Levels of Epstein Barr Virus DNA in Blood of Solid Organ Transplant Recipients and Their Value in Predicting Posttransplant Lymphoproliferative Disorders
... PTLD may be reversible in solid-organ transplant (SOT) recipients following reduction or discontinuation of immune suppression (27). Other therapeutic options include the ad- ministration of antiviral drugs (acyclovir, ...
7